You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
常山藥業(300255.SZ):肝素鈉注射液獲得烏茲別克斯坦註冊批文
格隆匯 04-13 16:57

格隆匯4月13日丨常山藥業(300255.SZ)公佈,公司於近日收到通知,公司藥品肝素鈉注射液獲得烏茲別克斯坦共和國衞生部簽發的藥品註冊證書。

肝素鈉注射液主要用於防治血栓形成或栓塞性疾病(如心肌梗塞、血栓性靜脈炎、肺栓塞等);各種原因引起的瀰漫性血管內凝血(DIC);也用於血液透析、體外循環、導管術、微血管手術等操作過程及某些血液標本或器械的抗凝處理。

次肝素鈉注射液獲得烏茲別克斯坦註冊批文,對公司拓展海外市場帶來一定積極影響。目前公司肝素製劑產品海外銷售收入佔公司營業總收入比例較低。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account